Drugs to treat attention deficit hyperactivity disorder (ADHD) have been a mainstay for Ireland’s Shire, so it’s no surprise that the company’s second-quarter earnings report was overshadowed by the ...

Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...

After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...

Apparently it really was an offer she couldn’t refuse. However, Talia Shire told The Post that if she had been in her brother Francis Ford Coppola‘s shoes, she wouldn’t have hired herself for the role ...